This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Study of the Prevalence of Acid Sphingomyelinase Deficiency/Niemann Pick AB and B Disease in Patients With Diffuse Interstitial Lung Disease | MicrobiomeTrials
← Back to trials NCT06869499
Study of the Prevalence of Acid Sphingomyelinase Deficiency/Niemann Pick AB and B Disease in Patients With Diffuse Interstitial Lung Disease Recruiting NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2025-06-05Est. Completion: 2029-03-01
Enrollment target: 200 participantsLocations Groupe Hospitalier Diaconesses Croix Saint-Simon, Paris, France Other microbiome trials you might be interested in Polycythemia Vera
The trial will be a phase III, randomised-controlled, multi-centre, international, open-label trial consisting of ruxoli…
Aberdeen, United Kingdom Est. completion Oct 31, 2028
Cystic Fibrosis Immunologic Deficiency Syndrome Turner Syndrome Congenital Hepatic Fibrosis Idiopathic Non-Cirrhotic Portal Hypertension
Background:
\- Noncirrhotic Portal Hypertension (NCPH) is caused by liver diseases that increase pressure in the blood …
Bethesda, United States Est. completion Sep 4, 2029
Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia
This randomized phase III trial studies rituximab with bendamustine hydrochloride or ibrutinib to see how well they work…
Birmingham, United States Est. completion Aug 7, 2018